O-I Glass, Inc. (Owens-Illinois, Inc.) 10-Q Summary
Business Context and Reporting Period
This filing is a Quarterly Report (Form 10-Q) for Owens-Illinois, Inc. for the period ended June 30, 2004. The company operates in the rigid packaging industry with two primary segments: Glass Containers and Plastics Packaging. A significant event during the period was the acquisition of BSN Glasspack, S.A. on June 21, 2004, for approximately $1.3 billion, which included 10 days of operations in the reported results.
Key Financial Metrics
Performance (Three Months Ended June 30, 2004):
- Net Sales: $1,716.3 million (up 8.7% from $1,579.6 million in 2003).
- Net Earnings: $82.0 million (up significantly from $17.0 million in 2003).
- Diluted EPS: $0.52 (compared to $0.08 in 2003).
- Segment EBIT: $247.9 million (Glass Containers: $188.9M; Plastics Packaging: $59.0M).
Performance (Six Months Ended June 30, 2004):
- Net Sales: $3,261.7 million (up 10.0% from $2,966.0 million in 2003).
- Net Earnings: $131.0 million (up from $51.4 million in 2003).
- Diluted EPS: $0.81 (compared to $0.28 in 2003).
- Operating Cash Flow: $220.7 million (improved from a negative $28.3 million in 2003).
Balance Sheet and Liquidity (as of June 30, 2004):
- Total Assets: $11,235.1 million.
- Total Debt: $6.70 billion (increased from $5.43 billion at Dec 31, 2003, primarily due to BSN acquisition financing).
- Cash and Equivalents: $301.8 million.
- Working Capital: Current assets of $2,728.4 million against current liabilities of $2,060.5 million.
- Unused Credit: $453.8 million available under the Secured Credit Agreement.
Material Changes vs. Prior Period
- Revenue Growth: Driven by a 13.5% increase in Glass Containers sales (due to price increases, favorable mix, and BSN acquisition) and a slight 2.0% increase in Plastics Packaging sales over the first six months.
- Profitability: Net earnings surged due to improved operating performance, a $20.6 million gain on the sale of real property, and the absence of a $37.4 million loss on the sale of notes receivable that impacted the prior year.
- Debt Levels: Long-term debt increased by approximately $937 million year-over-year to finance the BSN acquisition.
- Asbestos Liabilities: Accrued asbestos-related liabilities decreased to $537.7 million (from $628.7 million at year-end 2003) due to payments and reclassifications, though the company continues to face significant litigation exposure.
Guidance, Outlook, and Risks
Management Commentary and Outlook:
- Divestiture: On July 28, 2004, the company announced an agreement to sell its non-health-care blow-molded plastic container operations to Graham Packaging Company for approximately $1.2 billion. Proceeds will be used to pay down debt. This business will be reported as a discontinued operation starting in Q3 2004.
- BSN Integration: The company expects the BSN acquisition to increase annual interest expense by approximately $94 million. Additional inventory step-up charges of $26 million are expected in the third and fourth quarters of 2004.
- Asbestos Payments: The company anticipates total asbestos-related cash payments in 2004 will be moderately lower than in 2003.
Risks and Contingencies:
- Asbestos Litigation: The company is a defendant in approximately 32,000 asbestos lawsuits. While the company believes its accrued liability is sufficient, the ultimate liability cannot be estimated with certainty due to litigation volatility and co-defendant bankruptcies.
- Intellectual Property: A $14.5 million charge was recorded for the settlement of intellectual property litigation regarding plastic container patents.
- Goodwill Impairment: The company monitors goodwill for impairment. A $670 million charge was taken in 2003. The Asia Pacific Glass reporting unit remains sensitive to changes in cash flow projections.
- Pension Obligations: Significant estimates are required for pension assets and liabilities. A decline in asset values or discount rates could trigger additional non-cash charges.
Investor Verification Checklist
- Verify the closing status and regulatory approval of the $1.2 billion sale of the blow-molded plastic container business.
- Monitor the integration of BSN Glasspack and the realization of expected synergies versus the $94 million annual interest cost increase.
- Review the status of asbestos litigation and any potential for additional accruals beyond the current $537.7 million liability.
- Assess the impact of the $26 million inventory step-up charge on BSN's gross profit in upcoming quarters.
- Confirm the company's ability to maintain liquidity given the high debt load and ongoing asbestos cash outflows.